Fish, Algae or Krill Oil: Comparing Omega-3 Sources
The comparison that matters is cost per gram of EPA and DHA, not the source, and one of the three is usually several times more expensive per gram delivered.
The Short Answer
Omega-3 products are compared on source, and the variable that determines whether they work is the amount of EPA and DHA delivered. Trials showing meaningful effects generally used 2 g or more of combined EPA and DHA daily. A standard 1000 mg fish oil capsule commonly contains around 300 mg. Krill oil typically contains less per capsule again. Working out the cost per gram of active fatty acid usually settles the comparison before any discussion of absorption.
The Three Sources
Fish oil. The default. EPA and DHA are present, usually as ethyl esters in concentrated products or as triglycerides in re-esterified ones. Content varies enormously between products, from around 30 per cent of total oil in standard products to 80 per cent or more in concentrates.
Algal oil. The original source of marine omega-3, since fish accumulate it from algae. Predominantly DHA in most products, with some EPA-containing options. Suitable for vegans, and free of the fish-derived contaminant and sustainability concerns.
Krill oil. EPA and DHA bound partly to phospholipids rather than triglycerides, plus astaxanthin. Per-capsule content is typically low, often 100 to 150 mg of combined EPA and DHA.
What about plant ALA? Flax, chia and walnut provide alpha-linolenic acid, which converts to EPA at a low rate and to DHA at a very low rate, with conversion somewhat higher in women. It does not meaningfully raise the omega-3 index and is not a substitute.
Cod liver oil belongs in a separate category, since it also supplies vitamin A and D, and the vitamin A content constrains the dose.
The Cost-Per-Gram Comparison
| Product type | Typical EPA plus DHA per capsule | Capsules for 2 g |
|---|---|---|
| Standard 1000 mg fish oil | Around 300 mg | 6 to 7 |
| Concentrated fish oil | 500 to 800 mg | 3 to 4 |
| High-concentrate or liquid fish oil | 800 mg or more, or per teaspoon | 2 to 3, or one dose |
| Algal oil | 200 to 500 mg, mostly DHA | 4 to 10 |
| Krill oil | 100 to 150 mg | 13 to 20 |
The krill row is the decisive one. Reaching a trial-level dose from typical krill capsules requires a number nobody takes, which means most krill users are taking a fraction of the studied dose regardless of any absorption advantage.
The krill absorption argument, fairly stated: phospholipid-bound omega-3 is absorbed somewhat better per unit than ethyl esters, particularly without a fatty meal, and krill oil raises the omega-3 index at lower doses than an equivalent amount of ethyl ester fish oil. The advantage is real and it is not large enough to close a tenfold gap in delivered content.
The practical instruction: divide the price by the grams of EPA and DHA in the container, not by capsule count. That single calculation reorders most comparisons.
Form, Absorption and Timing
Triglyceride and re-esterified triglyceride forms are absorbed better than ethyl esters, particularly when taken without fat. Ethyl esters are cheaper to produce and are what many concentrates use.
Phospholipid form, as in krill, absorbs well per unit.
Take it with fat. Absorption is substantially better with a fat-containing meal, and this is the most reliable way to improve an inadequate response without raising the dose. It matters most for ethyl esters.
EPA against DHA. They are not interchangeable. DHA is the structural membrane component relevant to brain and retina; EPA appears more relevant to triglyceride lowering and to the cardiovascular trial that showed benefit, which used purified EPA. Algal products are often DHA-dominant, which suits a structural rationale and less well a triglyceride one.
Splitting the dose may improve tolerance and reduces reflux, which is the most common complaint.
Verification is available. The omega-3 index measures EPA and DHA in red cell membranes over three to four months, which makes this one of very few supplement categories where you can confirm the dose is working.
Quality, Contaminants and Sustainability
Oxidation is the main quality problem. Independent testing has found products exceeding recommended oxidation limits. Oxidised oil smells and tastes rancid, and there is a reasonable argument that oxidation products are undesirable. Refrigerate, buy quantities you will finish, and discard rancid product.
Contaminants. Heavy metals, dioxins and PCBs accumulate in fish, and refining removes most of them. Third-party testing for contaminants is worth having, particularly for products from smaller manufacturers. Algal oil avoids the issue by design.
Species and sourcing. Small oily fish such as anchovy and sardine accumulate fewer contaminants than large predatory fish.
Sustainability. A genuine consideration. Krill harvesting has ecological concerns given its position in the Antarctic food web, and fish oil sourcing varies in fishery management. Algal oil is produced by cultivation, which is the strongest position on this criterion.
Allergy. Fish and shellfish allergy are relevant; krill is a crustacean, and algal oil is the option for shellfish allergy.
Third-party certification covering oxidation, contaminants and content is the practical shortcut through all of this.
Safety Considerations at Dose
Bleeding. High-dose omega-3 affects platelet function, which matters alongside anticoagulants and antiplatelets, and before surgery. Discuss with the clinician or surgical team rather than assuming a supplement is neutral.
Atrial fibrillation. Several trials and analyses have reported increased incidence at higher doses, principally around 4 g daily. This is a genuine consideration for anyone taking high doses without a specific indication, and a reason to reduce once triglycerides have normalised.
Reflux and gastrointestinal upset, the most common complaint, reduced by taking with food and splitting the dose.
Vitamin A in cod liver oil, which constrains the dose and is teratogenic in excess.
Blood glucose, where some older reports suggested effects at high doses; the current evidence does not support a clinically relevant concern at usual doses.
Drug interactions beyond bleeding are limited, which makes this a relatively clean compound compared with several botanicals.
A Practical Recommendation
Eat oily fish two or three times weekly if you will. It frequently achieves an adequate omega-3 index without supplementation, and it is the cheapest route.
If supplementing, choose by cost per gram of EPA and DHA. A concentrated triglyceride-form fish oil or a liquid usually wins on this metric.
Target 2 g or more of combined EPA and DHA where there is a reason, principally elevated triglycerides or minimal fish intake. Lower doses are reasonable for general adequacy.
Take it with a fat-containing meal.
Choose algal oil if you avoid fish, have a shellfish allergy, or prioritise sustainability. Check whether it provides EPA as well as DHA if triglyceride lowering is the aim.
Choose krill only knowingly, accepting a much higher cost per gram delivered, and check the actual EPA and DHA content.
Verify with an omega-3 index at four months if the dose matters. Few supplement categories permit this and it is worth using.
Reduce the dose once the reason resolves, given the atrial fibrillation signal at higher intakes.
The AEONNN Perspective
AEONNN compares omega-3 products by cost per gram of EPA and DHA rather than by source, because that is the variable trials were run on. The Quality layer's most useful contribution here is a label instruction: read the fatty acid content, not the capsule weight, since a standard 1000 mg fish oil capsule commonly delivers around 300 mg of what matters.
That calculation resolves the krill question without needing to adjudicate the absorption debate. Phospholipid-bound omega-3 does absorb somewhat better per unit, and typical krill capsules contain 100 to 150 mg of combined EPA and DHA, so reaching a trial-level dose would require a number nobody takes.
This is also one of very few categories where the platform can close the loop, since the omega-3 index measures membrane EPA and DHA over three to four months. Dose in, status out, and a defensible decision about continuing, including the decision to stop where dietary oily fish already achieves the range. The Safety layer carries the atrial fibrillation signal reported at higher doses, which is why AEONNN reduces the dose once the reason for a high one resolves.
Pillar Matrix mapping
Inflammation and Immune Defense, Metabolic and Cardiovascular Health
Database Matrix layers
- Pharmacokinetics Layer (HMDB, PubChem)
- Quality / Formulation Layer (ConsumerLab, Labdoor)
- Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
- Safety Layer (DrugBank, FAERS)
Frequently Asked
Which omega-3 source is best?
The one delivering the most EPA and DHA per unit cost, which is usually a concentrated triglyceride-form fish oil or a liquid. Algal oil is the choice for vegans, shellfish allergy or sustainability.
How much EPA and DHA do I need?
2 g or more of combined EPA and DHA where there is a reason such as elevated triglycerides or minimal fish intake. A standard 1000 mg capsule commonly contains around 300 mg.
Is krill oil better absorbed?
Phospholipid-bound omega-3 absorbs somewhat better per unit. Typical krill capsules contain 100 to 150 mg of combined EPA and DHA, so the absorption advantage does not close a tenfold gap in content.
Does the form matter?
Triglyceride and re-esterified triglyceride forms absorb better than ethyl esters, particularly without fat. Taking any form with a fat-containing meal improves absorption substantially.
Are flax and chia adequate?
No. Alpha-linolenic acid converts to EPA at a low rate and to DHA at a very low rate, and it does not meaningfully raise the omega-3 index.
How do I know my dose is working?
The omega-3 index measures EPA and DHA in red cell membranes over three to four months. Few supplement categories permit this kind of verification.
Are there risks at high doses?
High doses affect platelet function, which matters alongside anticoagulants and before surgery, and several trials have reported increased atrial fibrillation incidence at around 4 g daily.
Evidence and review
Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.